BioSpace News Archive

The Government of Canada is working with all partners to protect the health and safety of Canadians and to reduce the spread of COVID-19 and the variants of concern in Canada.

First approved product containing estetrol (E4), the first new estrogen introduced in the U.S. in over 50 years

CPhI Discover (17 – 28 May 2021) is an annual online event that combines word-class content and insights with hundreds of virtual exhibitors – and will provide the industry with a new synergistic offering to sit alongside CPhI’s portfolio of in-person events.

Ardelyx, Inc. announced that on April 12, 2021, the compensation committee of the Company’s Board of Directors granted a non-qualified stock option award to purchase 125,622 shares of its common stock and a restricted stock unit award for 26,315 shares in connection with the commencement of employment of its new Chief People Officer, Sarah O’Brien, under the Company’s 2016 Employment Commencement Incentive Plan.

AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today that it experienced strong demand for its paid tests based on the cancer differentiation analysis technology (CDA) technology, or paid CDA-based tests,

Select Medical Holdings Corporation (“Select Medical”) (NYSE: SEM) today announced the appointment of Katherine R. Davisson to its Board of Directors (the “Board”), effective immediately.

Sesen Bio, a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, reported the grants of non-statutory stock options to four new employees in connection with the commencement of their employment with Sesen Bio.

Rafael Holdings, Inc., announced that on April 15, 2021 it made a grant to William Conkling of options to purchase 118,409 shares of Class B common stock of the Company with an exercise price equal to $40.85, the closing price of the Class B common stock on April 14, 2021, the trading day prior to the grant.

Gyroscope Therapeutics, a clinical-stage gene therapy company focused on treating diseases of the eye, today announced it has filed a registration statement on Form F-1 (the “Registration Statement”) with the U.S. Securities and Exchange Commission (the “SEC”) relating to a proposed initial public offering (“IPO”) in the United States of its American Depositary Shares (“ADSs”), each representing one ordinary share.

BioTech Medics, Inc. Announces the firm has begun operating Sumcoin Nodes directly and is exploring how to support the network with mining equipment.